Study to Evaluate the Effect of Delafloxacin on the Pharmacokinetics of Midazolam in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
VA Drug Interactions
Interventions
DRUG

Midazolam

Single 5 mg oral dose of midazolam syrup given in the AM on Day 1 and Day 8.

DRUG

Delafloxacin

Oral 450 mg delafloxacin tablets given twice daily (Q12h) on Days 3 to 8

Trial Locations (1)

78744

PPD Development, LP, Austin

Sponsors
All Listed Sponsors
lead

Melinta Therapeutics, Inc.

INDUSTRY